Operating Profit Endring Dato
AbbVie USD 3.2B 914M 2023-12
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.27B 819M 2023-12
Astellas Pharma JPY 5.22B 40.57B 2023-09
AstraZeneca USD 1.95B 502M 2023-09
Biogen USD 358.9M 200.1M 2023-12
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
Esperion Therapeutics USD -27533000 9.52M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
GlaxoSmithKline GBP 1.95B 192M 2023-09
Incyte USD 187.27M 27.44M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
J&J USD 4.83B 391M 2023-12
Kyowa Hakko Kirin JPY 37.03B 27.85B 2023-09
Merck USD -1933000000 7.68B 2023-12
Moderna USD 6M 2.02B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Opthea USD -71347750 6.5M 2023-06
Pfizer USD -6551000000 3.61B 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Teva Pharmaceutical Industries USD 355M 1B 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
United Therapeutics USD 260.1M 66.9M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Regeneron Pharmaceuticals Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.